Sutro Biopharma
STRO
STRO
120 hedge funds and large institutions have $753M invested in Sutro Biopharma in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
3.12% less ownership
Funds ownership: 89.44% → 86.32% (-3.1%)
3% less funds holding
Funds holding: 124 → 120 (-4)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
Holders
120
Holding in Top 10
3
Calls
$11K
Puts
$1K
Top Buyers
| 1 | +$9.79M | |
| 2 | +$8.83M | |
| 3 | +$5.18M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$4.57M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$4.04M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$12.6M | |
| 3 | -$10M | |
| 4 |
O
OrbiMed
New York
|
-$8.06M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$6.81M |